Search Results - "Tuy, Kaysaw"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance by Tuy, Kaysaw, Rickenbacker, Lucas, Hjelmeland, Anita B.

    Published in Redox biology (01-08-2021)
    “…Controlling reactive oxygen species (ROS) at sustainable levels can drive multiple facets of tumor biology, including within the cancer stem cell (CSC)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth by Gc, Sajina, Tuy, Kaysaw, Rickenbacker, Lucas, Jones, Robert, Chakraborty, Asmi, Miller, C Ryan, Beierle, Elizabeth A, Hanumanthu, Vidya Sagar, Tran, Anh N, Mobley, James A, Bellis, Susan L, Hjelmeland, Anita B

    Published in JCI insight (08-11-2022)
    “…One of the least-investigated areas of brain pathology research is glycosylation, which is a critical regulator of cell surface protein structure and function…”
    Get full text
    Journal Article
  4. 4
  5. 5

    DDRE-22. DISRUPTING REDOX BALANCE VIA THE TETRAHYDROBIOPTERIN PATHWAY IN GLIOBLASTOMA by Tuy, Kaysaw, GC, Sajina, Chen, Wei, Harrison, David, Aleman, John, Hjelmeland, Anita

    Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)
    “…Aberrant redox statuses are observed in glioblastoma (GBM), and we previously identified GTP cyclohydrolase I (GCH1) to be a redox regulator upregulated in…”
    Get full text
    Journal Article
  6. 6

    STEM-08. ST6Gal1-MEDIATED SILALYLATION IS CRITICAL FOR GLIOBLASTOMA GROWTH by GC, Sajina, Tuy, Kaysaw, Rickenbacker, Lucas, Jones, Brent, Chakraborty, Asmi, Miller, Ryan, Liu, Xiaoguang, Mobley, James, Bellis, Susan, Hjelmeland, Anita

    Published in Neuro-oncology (Charlottesville, Va.) (12-11-2021)
    “…Although altered cell surface glycosylation was one of the earliest modifications observed in neoplastic progression, this facet of cancer cell biology has…”
    Get full text
    Journal Article
  7. 7

    Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma by Jones, Amber B, Tuy, Kaysaw, Hawkins, Cyntanna C, Quinn, Colin H, Saad, Joelle, Gary, Sam E, Beierle, Elizabeth A, Ding, Lei, Rochlin, Kate M, Lamb, Lawrence S, Hjelmeland, Anita B

    Published in Cancers (15-08-2024)
    “…Glioblastoma (GBM) is an immunologically cold tumor, but several immunotherapy-based strategies show promise, including the administration of ex vivo expanded…”
    Get full text
    Journal Article